MPH Health Care AG

93M1

DE000A289V03

Pharmaceuticals

Market Closed - Deutsche Boerse AG Other stock markets 03:05:01 2024-04-26 am EDT			After market 11:43:05 am
20.6 ^EUR	-2.83%		20.2	-1.94%

Feb. 05	M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares	MT
2023	MPH Health Care AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI

MPH Mittelständische Pharma Holding AG Proposes Initial Dividend; Reports Earnings Preliminary IFRS Group Results for the First Quarter Ended March 31, 2016

May 27, 2016 at 02:00 am EDT

MPH Mittelständische Pharma Holding AG announced the start of dividend payments with an initial dividend proposal of 30 cents per share.

The company also reported earnings preliminary IFRS Group results for the first quarter ended March 31, 2016. For the first quarter, the company reported net profit amounted to EUR 8.69 million against EUR 1.26 million a year ago.

Latest news about MPH Health Care AG

M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares	Feb. 05	MT
MPH Health Care AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-06	CI
MPH Health Care AG Reports Earnings Results for the Full Year Ended December 31, 2022	23-06-19	CI
MPH Health Care AG Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-01	CI
MPH Health Care AG Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-01	CI
MPH Health Care AG Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-24	CI
MPH Health Care AG Reaffirms Earning Guidance for 2021	21-12-02	CI
Mph Health Care Ag Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-28	CI
Mph Health Care Ag Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-02	CI
M1 Kliniken AG completed the acquisition of 48.16% stake in HAEMATO AG from MPH Health Care AG.	20-06-30	CI
M1 Kliniken AG signed an agreement to acquire 48% stake in HAEMATO AG from MPH Health Care AG for €24.2 million.	20-06-09	CI
Mph Health Care Ag Reports Earnings Results for the Full Year Ended December 31, 2019	20-05-27	CI
Mph Health Care Ag Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-29	CI
Mph Health Care Ag Declares Dividend for 2018, Due on 22 July 2019	19-07-18	CI
MPH Health Care AG Proposes an Unchanged Dividend	19-05-23	CI
Mph Health Care Ag Reports Earnings Results for the Full Year Ended December 31, 2018	19-05-22	CI
MPH Health Care AG Announces Unaudited Earnings Results for the Six Months Ended June 30, 2018	18-08-30	CI
MPH Health Care AG Approves Dividend for Fiscal 2017	18-07-13	CI
MPH Health Care AG Proposes Dividend for the Financial Year 2017	18-05-11	CI
MPH Health Care AG Reports Preliminary Earnings Results for the First Quarter of 2018	18-05-10	CI
MPH Health Care AG Proposes Dividend for 2017	18-03-29	CI
MPH Health Care AG Reports Preliminary Consolidated Earnings Results for the Financial Year 2017	18-03-29	CI
MPH Health Care AG Reports Preliminary Earnings Results for the Third Quarter and Nine Months of 2017	17-10-30	CI
MPH Mittelständische Pharma Holding AG Announces Resignation of Dr. Christian Pahl as Management Board Member	17-07-07	CI
MPH Mittelständische Pharma Holding AG Announces IFRS Group Earnings Results for Fiscal Year 2016	17-03-16	CI

Chart MPH Health Care AG

Duration

Period

More charts

Company Profile

MPH Health Care AG, formarly MPH Mittelstaendische Pharma Holding AG, is a Germany-based pharmaceuticals and investment company. The Company focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The Company's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

20.6 EUR

Average target price

62 EUR

Spread / Average Target

+200.97%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
MPH HEALTH CARE AG	+25.61%	97.23M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.78B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.89B
SANDOZ GROUP AG	+10.86%	14.45B
CIPLA LIMITED	+13.07%	13.63B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.49B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.85B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.06B

Generic Pharmaceuticals

MPH Health Care AG

Equities

93M1

DE000A289V03

Pharmaceuticals

MPH Mittelständische Pharma Holding AG Proposes Initial Dividend; Reports Earnings Preliminary IFRS Group Results for the First Quarter Ended March 31, 2016

Latest news about MPH Health Care AG

Chart MPH Health Care AG

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Generic Pharmaceuticals